These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15324478)

  • 1. Oil-based formulations for oral delivery of insulin.
    Li CL; Deng YJ
    J Pharm Pharmacol; 2004 Sep; 56(9):1101-7. PubMed ID: 15324478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation optimization of water-in-oil-water multiple emulsion for intestinal insulin delivery.
    Onuki Y; Morishita M; Takayama K
    J Control Release; 2004 May; 97(1):91-9. PubMed ID: 15147807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lyophilization of water-in-oil emulsions to prepare phospholipid-based anhydrous reverse micelles for oral peptide delivery.
    Wang T; Wang N; Hao A; He X; Li T; Deng Y
    Eur J Pharm Sci; 2010 Mar; 39(5):373-9. PubMed ID: 20093181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo evaluation of a novel oral insulin formulation.
    Ma EL; Ma H; Liu Z; Zheng GX; Duan MX
    Acta Pharmacol Sin; 2006 Oct; 27(10):1382-8. PubMed ID: 17007747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stability of insulin-loaded polybutylcyanoacrylate nanoparticles in an oily medium and the hypoglycemic effect in diabetic rats.
    Hou ZQ; Zhang ZX; Xu ZH; Zhang H; Tong ZF; Leng YS
    Yao Xue Xue Bao; 2005 Jan; 40(1):57-64. PubMed ID: 15881329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
    Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
    Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and characterization of an oily-based system for oral delivery of insulin.
    Elsayed A; Remawi MA; Qinna N; Farouk A; Badwan A
    Eur J Pharm Biopharm; 2009 Oct; 73(2):269-79. PubMed ID: 19508890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
    Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
    J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery.
    Kumar A; Lahiri SS; Singh H
    Int J Pharm; 2006 Oct; 323(1-2):117-24. PubMed ID: 16828246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A lecithin-based microemulsion of rh-insulin with aprotinin for oral administration: Investigation of hypoglycemic effects in non-diabetic and STZ-induced diabetic rats.
    Cilek A; Celebi N; Tirnaksiz F; Tay A
    Int J Pharm; 2005 Jul; 298(1):176-85. PubMed ID: 15950411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel fibrillar insulin formulations for oral administration: Formulation and in vivo studies in diabetic mice.
    Dekel Y; Glucksam Y; Margalit R
    J Control Release; 2010 Apr; 143(1):128-35. PubMed ID: 20043960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS; Ramakrishna S; Saini TR; Diwan PV
    Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral delivery system of insulin microspheres: effect on relative hypoglycemia of diabetic albino rats.
    Senthil Rajan D; Mandal UK; Veeran Gowda K; Bose A; Ganesan M; Pal TK
    Boll Chim Farm; 2004 Oct; 143(8):315-8. PubMed ID: 15884295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioadhesive interaction and hypoglycemic effect of insulin-loaded lectin-microparticle conjugates in oral insulin delivery system.
    Kim BY; Jeong JH; Park K; Kim JD
    J Control Release; 2005 Feb; 102(3):525-38. PubMed ID: 15681076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin microcrystal suspension as a long-acting formulation for pulmonary delivery.
    Kwon JH; Lee BH; Lee JJ; Kim CW
    Eur J Pharm Sci; 2004 Jun; 22(2-3):107-16. PubMed ID: 15158896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological effect of orally delivered insulin facilitated by multilayered stable nanoparticles.
    Woitiski CB; Neufeld RJ; Veiga F; Carvalho RA; Figueiredo IV
    Eur J Pharm Sci; 2010 Nov; 41(3-4):556-63. PubMed ID: 20800679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and in-vivo evaluation of insulin-loaded chitosan phthalate microspheres for oral delivery.
    Ubaidulla U; Khar RK; Ahmed FJ; Panda AK
    J Pharm Pharmacol; 2007 Oct; 59(10):1345-51. PubMed ID: 17910808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative estimation of the effects of bile salt surfactant systems on insulin stability and permeability in the rat intestine using a mass balance model.
    Lane ME; O'driscoll CM; Corrigan OI
    J Pharm Pharmacol; 2005 Feb; 57(2):169-75. PubMed ID: 15720779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-sensitive microsphere delivery increases oral bioavailability of calcitonin.
    Lamprecht A; Yamamoto H; Takeuchi H; Kawashima Y
    J Control Release; 2004 Jul; 98(1):1-9. PubMed ID: 15245884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel drug delivery system for type 1 diabetes: insulin-mimetic vanadyl-poly(gamma-glutamic acid) complex.
    Karmaker S; Saha TK; Yoshikawa Y; Yasui H; Sakurai H
    J Inorg Biochem; 2006 Sep; 100(9):1535-46. PubMed ID: 16824605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.